Press Release
Posted April 3, 2018
Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder.
Data Sheets, 70.97 KB
A 204 °C (400 °F) maximum service temperature, stayed-aramid felt filter cartridge for use in pulse jet style dust collectors where high differential pressure and high cleaning pressures are required due to aggressive dust loading.
Technical Information, 471.19 KB
Two cleaning protocols outlined in this application note potentially extend the lifetime of a GORE Protein Capture Device in the event that pressure elevates over the expected lifetime of the device.
Press Release
Posted March 21, 2018
W. L. Gore & Associates today announced a collaboration with digital health startup Bonbouton to explore material solutions in advanced sensor technology and enable practical smart fabrics for assistive apparel and digital health applications.